Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by March

Name: Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by March
Uploaded: 2022-01-30T22:40:28+00:00
Duration: P76S
Description: Pfizer CEO Albert Bourla sits down with CNBC&apos;s Meg Tirrell and the &apos;Squawk Box&apos; team to discuss the company&apos;s Covid-19

Video Credit: Rumble - Duration: 01:16s - Published on January 30, 2022

Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by March

Pfizer CEO Albert Bourla sits down with CNBC's Meg Tirrell and the 'Squawk Box' team to discuss the company's Covid-19 vaccine booster strategy, including a potential shot targeting the omicron variant.

For access to live and exclusive video from CNBC subscribe to CNBC PRO:

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Pfizer CEO Promises Omicron Vaccine By March [Video]

Pfizer CEO Promises Omicron Vaccine By March

Pfizer CEO Promises Omicron Vaccine By March

Credit: Rumble Duration: 14:22Published on January 29, 2022

Dr. Robert Malone

Moderna said on Wednesday that it had started a mid-stage study, testing a booster dose of its COVID vaccine specifically designed to target the Omicron variant, a day after rival Pfizer launched a..

Credit: Rumble Duration: 05:13Published on January 28, 2022

Pfizer CEO Albert Bourla says “Two doses of the vaccine offers very limited protection, if any.”

Credit: Rumble Duration: 00:38Published on January 26, 2022

Pfizer CEO Bourla: Omicron-specific Covid vaccine will be ready by March

You Might Like

Related videos from verified sources